Publication | Closed Access

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

Hematological MalignancyLymphoid NeoplasiaOncologyImmunologyHematologyPharmacotherapyImmunotherapyMedicineFludarabine Versus CyclophosphamideCancer Research